These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6542721)

  • 61. Babesia bovis: isolation of a protective antigen by using monoclonal antibodies.
    Wright IG; White M; Tracey-Patte PD; Donaldson RA; Goodger BV; Waltisbuhl DJ; Mahoney DF
    Infect Immun; 1983 Jul; 41(1):244-50. PubMed ID: 6345394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Babesia divergens: combination of dead and live parasites in an irradiated vaccine.
    Purnell RE; Lewis D
    Res Vet Sci; 1981 Jan; 30(1):18-21. PubMed ID: 7244378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and characterization of profilin antigen among Babesia species as a common vaccine candidate against babesiosis.
    Munkhjargal T; Aboge GO; Ueno A; Aboulaila M; Yokoyama N; Igarashi I
    Exp Parasitol; 2016 Jul; 166():29-36. PubMed ID: 27003460
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ; Wood DD
    J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular identification and antigenic characterization of Babesia divergens Erythrocyte Binding Protein (BdEBP) as a potential vaccine candidate.
    El-Sayed SAE; Rizk MA; Terkawi MA; Yokoyama N; Igarashi I
    Parasitol Int; 2017 Dec; 66(6):721-726. PubMed ID: 28743470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of immunoreactive polypeptides of Babesia equi parasite during immunization.
    Kumar S; Malhotra DV; Nichani AK
    Vet Parasitol; 2002 Aug; 107(4):295-301. PubMed ID: 12163241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture.
    Schetters TP; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1992 May; 14(3):295-305. PubMed ID: 1625906
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
    Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK
    Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The protective activity of serum and fractionated serum from rats against Babesia divergens.
    Ben Musa N; Dawoud HA
    J Egypt Soc Parasitol; 2004 Aug; 34(2):407-22. PubMed ID: 15287167
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
    Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
    Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Field use of an irradiated blood vaccine to protect cattle against redwater (Babesia divergens infection) on a farm in Dorset.
    Purnell RE; Lewis D; Brabazon A; Francis LM; Young ER; Grist C
    Vet Rec; 1981 Jan; 108(2):28-31. PubMed ID: 7015679
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of the indirect fluorescent antibody test for Babesia major and Theileria mutans in Britain.
    Morzaria SP; Brocklesby DW; Harradine DL
    Vet Rec; 1977 Jun; 100(23):484-7. PubMed ID: 327676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants.
    Siddiqui WA; Taylor DW; Kan SC; Kramer K; Richmond-Crum SM; Kotani S; Shiba T; Kasumoto S
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):199-203. PubMed ID: 120768
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Successful homologous vaccination against Babesia bovis using a heparin-binding fraction of infected erythrocytes.
    Goodger BV; Commins MA; Wright IG; Waltisbuhl DJ; Mirre GB
    Int J Parasitol; 1987 Apr; 17(4):935-40. PubMed ID: 3583543
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
    Lew AM; Anders RF; Edwards SJ; Langford CJ
    Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Babesia major in Britain: cross-immunity trials with Babesia divergens in splenectomised calves.
    Brocklesby DW; Harradine DL; Young ER
    Res Vet Sci; 1976 Nov; 21(3):300-2. PubMed ID: 1025635
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium.
    Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ
    Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vaccination against bovine babesiosis with drug-controlled live parasites.
    Gray JS; Langley RJ; Brophy PO; Gannon P
    Vet Rec; 1989 Sep; 125(14):369-72. PubMed ID: 2683338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.